Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON32253Not yet recruiting
Randomised, open-label trial of clopidogrel in cardiac ischemia and acute coronary syndrome (ACS) (2 arms), sponsored by Stichting Lijf en Leven. Primary endpoint: Primary composite cardiovascular endpoint. Planned start Dec 2008; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON32253.